| Epidemiologic classification of human papillomavirus types associated with cervical cancer N Muñoz, FX Bosch, S De Sanjosé, R Herrero, X Castellsagué, KV Shah, ... New England journal of medicine 348 (6), 518-527, 2003 | 9529 | 2003 |
| Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study R Herrero, X Castellsagué, M Pawlita, J Lissowska, F Kee, P Balaram, ... Journal of the National Cancer Institute 95 (23), 1772-1783, 2003 | 1795 | 2003 |
| Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis GM Clifford, S Gallus, R Herrero, N Munoz, PJF Snijders, S Vaccarella, ... The Lancet 366 (9490), 991-998, 2005 | 1615 | 2005 |
| Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium M Hashibe, P Brennan, S Chuang, S Boccia, X Castellsague, C Chen, ... Cancer Epidemiology Biomarkers & Prevention 18 (2), 541-550, 2009 | 1603 | 2009 |
| Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer … M Hashibe, P Brennan, S Benhamou, X Castellsague, C Chen, ... Journal of the National Cancer Institute 99 (10), 777-789, 2007 | 1538 | 2007 |
| Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners X Castellsagué, FX Bosch, N Muñoz, CJLM Meijer, KV Shah, ... New England journal of medicine 346 (15), 1105-1112, 2002 | 1254 | 2002 |
| Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study V Moreno, FX Bosch, N Muñoz, CJLM Meijer, KV Shah, JMM Walboomers, ... The Lancet 359 (9312), 1085-1092, 2002 | 1211 | 2002 |
| Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study N Muñoz, S Franceschi, C Bosetti, V Moreno, R Herrero, JS Smith, ... The Lancet 359 (9312), 1093-1101, 2002 | 1170 | 2002 |
| Epidemiology and molecular pathology of gallbladder cancer EC Lazcano‐Ponce, JF Miquel, N Muñoz, R Herrero, C Ferrecio, ... CA: a cancer journal for clinicians 51 (6), 349-364, 2001 | 1058 | 2001 |
| Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention X Castellsagué, M Díaz, S De Sanjosé, N Muñoz, R Herrero, S Franceschi, ... Journal of the National Cancer Institute 98 (5), 303-315, 2006 | 1055 | 2006 |
| Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica R Herrero, A Hildesheim, C Bratti, ME Sherman, M Hutchinson, J Morales, ... Journal of the National Cancer Institute 92 (6), 464-474, 2000 | 908 | 2000 |
| Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis L Bruni, M Diaz, L Barrionuevo-Rosas, R Herrero, F Bray, FX Bosch, ... The Lancet global health 4 (7), e453-e463, 2016 | 902 | 2016 |
| Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial A Hildesheim, R Herrero, S Wacholder, AC Rodriguez, D Solomon, ... Jama 298 (7), 743-753, 2007 | 836 | 2007 |
| The carcinogenicity of human papillomavirus types reflects viral evolution M Schiffman, R Herrero, R DeSalle, A Hildesheim, S Wacholder, ... Virology 337 (1), 76-84, 2005 | 791 | 2005 |
| HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica M Schiffman, R Herrero, A Hildesheim, ME Sherman, M Bratti, ... Jama 283 (1), 87-93, 2000 | 789 | 2000 |
| Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections AC Rodríguez, M Schiffman, R Herrero, S Wacholder, A Hildesheim, ... Journal of the National Cancer Institute 100 (7), 513-517, 2008 | 718 | 2008 |
| Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer JS Smith, R Herrero, C Bosetti, N Munoz, FX Bosch, J Eluf-Neto, ... Journal of the National Cancer Institute 94 (21), 1604-1613, 2002 | 656 | 2002 |
| A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica PE Castle, M Schiffman, R Herrero, A Hildesheim, AC Rodriguez, ... The Journal of infectious diseases 191 (11), 1808-1816, 2005 | 614 | 2005 |
| Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica R Herrero, W Quint, A Hildesheim, P Gonzalez, L Struijk, HA Katki, ... PloS one 8 (7), e68329, 2013 | 598 | 2013 |
| Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study M Plummer, R Herrero, S Franceschi, CJLM Meijer, P Snijders, FX Bosch, ... Cancer Causes & Control 14, 805-814, 2003 | 598 | 2003 |
Mark SchiffmanNational Cancer InstituteVerified email at mail.nih.gov
